Snow Leopard Consulting LLC

Snow Leopard Consulting provides a full suite of services to optimize preclinical development and support biotechnology companies and venture capital-backed licensing decisions. Our Preclinical Program Design offers integrated, resource-efficient programs, managing Contract Research Organizations (CROs) through every phase to ensure cost-effectiveness and timely results. We specialize in Molecule / Antibody Selection Optimization and Due Diligence, conducting target safety reviews, in vitro and in vivo triaging studies, and evaluating preclinical data to support licensing decisions. Our due diligence services help venture capital firms assess preclinical assets, enabling informed investment and licensing decisions. We design and implement Study Outlines and Protocols for IND-enabling studies, including NGLP and GLP-compliant toxicology, safety pharmacology, pharmacokinetics (ADME), and mechanistic studies. Our team excels in IND Documentation and Authoring, preparing pharmacology summaries, nonclinical overviews, and safety sections for Investigator Brochures (IBs), NDAs, and BLAs. With a focus on efficiency, we develop IND Filing Strategies to streamline submissions and reduce resource needs. Our Regulatory Agency Representation ensures clear communication through prepared briefing documents, while we also manage Health Authority Waivers for carcinogenicity and reproductive toxicology studies. Snow Leopard Consulting provides critical preclinical insights, expert due diligence, and clear paths to clinical success. We help venture capital firms and BioPharma companies optimize timelines, reduce costs, and ensure licensing decisions are backed by scientifically robust, resource-efficient strategies. ©️